We’ve known for years that different patients respond to different treatments. But for the vast majority of diseases, we’ve had no way of knowing which treatment will work best for the individual. The result? Drugs are developed for what is believed to be the “average patient,” even though there’s no such thing, and patients are prescribed drug after drug until, hopefully, they find one that works. Meanwhile, they’re putting their lives on hold while their disease worsens and billions of dollars are wasted in prescription costs. Now, with our breakthrough ability to determine which drug will work best for each patient, we can do better.
Our platform uses the largest protein interaction database ever built to better understand diseases and how to treat them. As more data is added, we will be able to improve patients’ treatment options to help them get the right treatment.
The path to effective treatment has never been clear or easy. So, we created a map.
Interpreting RNA data has eluded scientists for decades, so our team took a new approach, combining RNA expression data with a decade-in-the-making map of protein interactions to create a new platform. Now, we’re able to use a patient’s RNA to decipher the biology of that individual’s disease and predict his or her response to specific treatments.